Abstract
Objectives
To assess the incidence, pathogens, and outcome of complicated parapneumonic effusions or empyemas in a medical intensive care unit (MICU) patients with pleural effusions.
Design and setting
Prospective study of febrile MICU patients with pleural effusion carried out in a tertiary care hospital between April 2001 and September 2003.
Patients
The study included 175 patients with a temperature above 38° for more than 8 h with evidence of pleural effusion confirmed by chest radiography and ultrasound.
Intervention
Routine thoracentesis and effusion cultures.
Results
The prevalence of complicated parapneumonic effusions or thoracic empyemas in febrile MICU patients with pleural effusions was 45% (78/175). A total of 78 micro-organisms were isolated from the pleural fluid of 58 patients (positive microbiological culture 74%) including aerobic Gram-negative (n = 45), aerobic Gram-positive (n = 23), anaerobic (n = 5), Myobacterium tuberculosis (n = 3), and Candida (n = 2). The infection-related mortality rate of complicated parapneumonic effusions or empyemic patients in the MICU was 41% (32/78).
Conclusion
The development of complicated parapneumonic effusions or thoracic empyemas in MICU patients is a high-mortality disease. The increasing incidence of aerobic Gram-negative pathogens in empyema has become a more urgent problem.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fartoukh M, Azoulay E, Galliot R, Le Gall JR, Baud F, Chevret S, Schlemmer B (2002) Clinically documented pleural effusions in medical ICU patients: how useful is routine thoracentesis? Chest 121:178–184
Tu CY, Hsu WH, Hsia TC, Hsia TC, Chen HJ, Tsai KD, Hung CW, Shih CM (2004) Pleural effusions in febrile medical ICU patients: chest ultrasound study. Chest 126:1274–1280
Mattison LE, Coppage L, Alderman DF, Herlong JO, Sahn SA (1997) Pleural effusions in the medical ICU: prevalence, causes, and clinical implications. Chest 111:1018–1025
Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 274:639–644
Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129:433–440
Campbell GD, Niederman MS, Broughton WA, Gleeson K, Hornick DB, Lynch JP, Craven DE, Fein AM, Fink MP, Mandell LA, Mason CM, Torres A, Wunderink RG (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 153:1711–1725
Erbay H, Yalcin AN, Serin S, Turgut H, Tomatir E, Cetin B, Zencir M (2003) Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med 29:1482–1488
Leroy O, Meybeck A, d'Escrivan T, Devos P, Kipnis E, Georges H (2003) Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med 29:2170–2173
Brook I, Frazier EH (1993) Aerobic and anaerobic microbiology of empyema: a retrospective review in two military hospitals. Chest 103:1502–1507
Varkey B, Rose HD, Kutty CP, Politis J (1981) Empyema thoracis during a ten-year period: analysis of 72 cases and comparison to a previous study (1952–1967). Arch Intern Med 141:1771–1776
Smith JA, Mullerworth MH, Westlake GW, Tatoulis J (1991) Empyema thoracis: a 14-year experience in a teaching center. Ann Thorac Surg 51:39–42
Vianna NJ (1971) Nontuberculous bacterial empyema in patients with and without underlying disease. JAMA 215:69–75
Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155
Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386
Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 115:462–474
Feldman C, Ross S, Mahomed AG, Omar J, Smith C (1995) The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med 86:187–192
Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P (1994) Severe community-acquired pneumonia etiology, epidemiology, and prognostic factors. Chest 105:1487–1495
Rello J, Quintana E, Ausina V, Net A, Prats G (1993) A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 103:232–235
Valles J, Mesalles E, Mariscal D, del Mar Fernandez M, Pena R, Jimenez JL, Rello J (2003) A 7-year study of severe hospital-acquired pneumonia requiring ICU admission. Intensive Care Med 29:1981–1988
Pareja A, Bernal C, Leyva A, Piedrola G, Maroto MC (1992) Etiologic study of patients with community-acquired pneumonia. Chest 101:1207–1210
Rello J, Bodi M, Mariscal D, Navarro M, Diaz E, Gallego M, Valleset J (2003) Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 123:174–180
Emori TG, Gaynes RP (1993) An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 6:428–442
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Tu, CY., Hsu, WH., Hsia, TC. et al. The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 32, 570–576 (2006). https://doi.org/10.1007/s00134-005-0064-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-005-0064-7